What do you think the chance of success is of convincing the Takeovers panel that "amounts to a collateral benefit not received by the other minority shareholders. Basically, that is, they are being preferentially treated"
In your opinion?
EMR Price at posting:
$2.23 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)